• 1. An amorphous lanthanum–iridium solid solution with an open structure for efficient water splitting?
  Wei Sun,Chenglong Ma,Xinlong Tian,Jianjun Liao,Ji Yang,Chengjun Ge,Weiwei Huang J. Mater. Chem. A, 2020,8, 12518-12525
• 2. An Assessment of the Laminar Hypersonic Double-Cone Experiments in the LENS-XX Tunnel
  JaideepRay,PatrickBlonigan,EricT.Phipps,KathrynMaupin
• 3. An all-solid-state asymmetric device based on a polyaniline hydrogel for a high energy flexible supercapacitor?
  Hamid Heydari,Mohammad B. Gholivand New J. Chem., 2017,41, 237-244
• 4. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782
• 5. An atmosphere and light tuned highly diastereoselective synthesis of cyclobuta/penta[b]indoles from aniline-tethered alkylidenecyclopropanes with alkynes?
  Bo Cao,Yin Wei Chem. Commun., 2018,54, 2870-2873

• Solvents and Organic Chemicals Organic Compounds Alcohol/Ether

Professional Introduction to Compound with CAS No. 770-71-8 and Product Name: 1-adamantylmethanol

The compound in question, identified by the chemical abstracts service number CAS No. 770-71-8, is a significant molecule in the realm of organic chemistry and pharmaceutical research. Its systematic name, 1-adamantylmethanol, denotes a derivative of adamantane, a hydrocarbon known for its unique three-dimensional diamond-like structure. This structural motif imparts distinctive physicochemical properties, making it a valuable scaffold in medicinal chemistry and material science.

1-adamantylmethanol (CAS No. 770-71-8) has garnered attention due to its potential applications in drug design and development. The adamantane core, characterized by its high lipophilicity and stability, enhances the metabolic half-life and bioavailability of associated molecules. Recent studies have highlighted its utility as a pharmacophore in the synthesis of novel therapeutic agents targeting various biological pathways.

In the context of contemporary pharmaceutical research, 1-adamantylmethanol has been explored as a key intermediate in the preparation of small-molecule inhibitors. Its rigid framework provides a stable platform for functional group modifications, enabling the creation of compounds with tailored biological activities. For instance, researchers have leveraged this scaffold to develop inhibitors of enzymes implicated in inflammatory responses and cancer progression.

One notable application of 1-adamantylmethanol is in the synthesis of radiolabeled compounds for positron emission tomography (PET) imaging. The adamantane moiety facilitates the attachment of radioactive isotopes without compromising structural integrity, allowing for high-resolution visualization of biological processes in vivo. This has opened new avenues in diagnostic medicine, particularly in oncology and neurology.

The chemical properties of 1-adamantylmethanol also make it a promising candidate for materials science applications. Its resistance to thermal degradation and solubility in organic solvents have been exploited in the formulation of polymers and coatings with enhanced durability. Furthermore, its ability to interact with other molecules via hydrogen bonding has been utilized in the design of supramolecular assemblies.

Recent advancements in computational chemistry have further elucidated the potential of 1-adamantylmethanol as a building block for complex molecular architectures. Molecular modeling studies suggest that its rigid structure can stabilize pharmacologically active conformations, improving drug-receptor interactions. These insights have guided the rational design of next-generation therapeutics with improved efficacy and selectivity.

The synthesis of 1-adamantylmethanol (CAS No. 770-71-8) typically involves multi-step organic transformations starting from commercially available precursors such as adamantane or its derivatives. Advances in synthetic methodologies have streamlined these processes, making large-scale production more feasible. Catalytic techniques have been particularly instrumental in achieving high yields and purity levels required for pharmaceutical applications.

Industrial applications of 1-adamantylmethanol are also emerging beyond pharmaceuticals. Its incorporation into specialty chemicals has led to innovative solutions in fragrances and cosmetics, where its stability and unique olfactory properties are highly valued. Additionally, its use as an additive in lubricants has been investigated due to its ability to improve thermal conductivity and reduce friction.

The future prospects for 1-adamantylmethanol are promising, with ongoing research exploring its role in emerging fields such as nanotechnology and biomedicine. Its integration into nanocarriers for drug delivery systems holds significant potential for enhancing therapeutic outcomes. Moreover, its compatibility with biodegradable polymers makes it an attractive candidate for sustainable medical applications.

In conclusion, 1-adamantylmethanol, identified by CAS No. 770-71-8, is a versatile compound with far-reaching implications across multiple scientific disciplines. Its unique structural features and functional adaptability have positioned it as a cornerstone molecule in modern chemistry and medicine. As research continues to uncover new applications, the significance of this compound is poised to grow even further.

• 13393-93-6(Tetrahydroabietyl Alcohol)
• 54843-86-6(Cyclohexanemethanol, octyl-)
• 89452-26-6(Cyclohexanemethanol, 6-ethyl-2,2-dimethyl-, trans-)
• 89452-25-5(Cyclohexanemethanol, 6-ethyl-2,2-dimethyl-, cis-)
• 1333-89-7(Abitol)
• 24887-73-8(1,2,4-Cyclohexanetriethanol,b2,b4,1-trimethyl-)
• 24869-54-3([1,1'-Bicyclohexyl]-1-methanol)
• 826-45-9([4-(hydroxymethyl)-1-bicyclo[2.2.2]octanyl]methanol)
• 34026-01-2(Cyclohexanemethanol,2,6,6-trimethyl-)
• 26919-42-6(3,5-Dimethyl-1-adamantanemethanol)